CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women
- PMID: 16406421
- DOI: 10.1016/j.toxlet.2005.11.014
CYP19 (TTTA)n polymorphism and breast cancer risk in Brazilian women
Abstract
A prolonged or increased exposure to endogenous estrogens associated with genetic factors are considered to be the main risk factors for breast cancer. The CYP19 gene encodes the enzyme aromatase, which catalyzes the conversion of androgens into estrogens. CYP19 alleles containing different numbers of tetranucleotide TTTA repeats in intron 4 have been associated with increased breast cancer risk. In this study we investigated, for the first time, the frequency of CYP19 (TTTA)n alleles in a South American population (n = 475) and analyzed the risk for developing breast cancer in a case-control study comprising 135 cases and 270 age-matched controls. It is shown that Brazilians possess not only the alleles identified in all the other populations studied so far (alleles containing from 7 to 13 TTTA repeats), but also the (TTTA)6 allele, that had never been described before. The (TTTA)10 allele was three times more frequent in cases when compared to controls and presented a significant positive association (p = 0.048) with breast cancer development in Brazilians.
Similar articles
-
The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women.Oncol Rep. 2009 Sep;22(3):487-92. Oncol Rep. 2009. PMID: 19639193
-
Association of the genetic polymorphism of the CYP19 intron 4[TTTA]n repeat with familial prostate cancer risk in a Japanese population.Anticancer Res. 2003 Nov-Dec;23(6D):4941-6. Anticancer Res. 2003. PMID: 14981949
-
A tetranucleotide repeat polymorphism in the CYP19 gene and breast cancer susceptibility in a Greek population exposed and not exposed to pesticides.Toxicol Lett. 2004 Jun 15;151(1):267-71. doi: 10.1016/j.toxlet.2004.01.024. Toxicol Lett. 2004. PMID: 15177662
-
A systematic review of genetic polymorphisms and breast cancer risk.Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):843-54. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10548311
-
Searching for susceptibility alleles: emphasis on bilateral breast cancer.Int J Cancer. 2007 Aug 15;121(4):921-3. doi: 10.1002/ijc.22785. Int J Cancer. 2007. PMID: 17444500 Review. No abstract available.
Cited by
-
A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.BMC Cancer. 2010 Feb 9;10:36. doi: 10.1186/1471-2407-10-36. BMC Cancer. 2010. PMID: 20144226 Free PMC article.
-
Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3457-66. doi: 10.1158/1055-9965.EPI-08-0517. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 19064562 Free PMC article. Clinical Trial.
-
Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.BMC Med Genet. 2009 Dec 16;10:139. doi: 10.1186/1471-2350-10-139. BMC Med Genet. 2009. PMID: 20015405 Free PMC article.
-
Association between telomere length and CYP19 TTTA repetition polymorphism in healthy and breast cancer-diagnosed women.Breast Cancer (Dove Med Press). 2017 Jan 13;9:21-27. doi: 10.2147/BCTT.S125431. eCollection 2017. Breast Cancer (Dove Med Press). 2017. PMID: 28144163 Free PMC article.
-
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review.Cells. 2024 Nov 26;13(23):1958. doi: 10.3390/cells13231958. Cells. 2024. PMID: 39682707 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical